'Dopesick', which took a closer look at Purdue Pharma, the company that promoted OxyContin, was a personal one for the actor, whose nephew died from a drug overdose. This show was Keaton's first TV show
US actor Michael Keaton accepts the award for Outstanding Lead Actor In A Limited Or Anthology Series Or Movie for "Dopesick" onstage during the 74th Emmy Awards at the Microsoft Theater in Los Angeles, California. Pic/AFP
Actor Michael Keaton on Tuesday bagged his first Emmy award for lead actor in a limited or anthology series for his role in the Hulu drama series 'Dopesick'.
In the eight-episode drama miniseries about the rise and fall of the opioid crisis, Keaton played the role of Dr. Samuel Finnix.
ADVERTISEMENT
'Dopesick', which took a closer look at Purdue Pharma, the company that promoted OxyContin, was a personal one for the actor, whose nephew died from a drug overdose. This show was Keaton's first TV show.
During his award acceptance speech, the actor called out his "doubters" over the years, saying, "Over the years we've all been through a lot of tough times. There have been some doubters. I've had some doubters. You know what? We're cool. But I also had those people for all these years when times were rough who were the true believers."
Also Read: SAG Awards: Michael Keaton dedicates award to late nephew in emotional speech
As per Deadline, in 2016, Keaton's nephew, Michael, died after a drug addiction battle. The actor had previously said that losing his nephew influenced his decision to work in 'Dopesick', a limited series adaptation of Beth Macy's book of the same name.
With this Emmy win, Keaton has trumped against Colin Firth for HBO Max's 'The Staircase', Andrew Garfield for FX's 'Under the Banner of Heaven', Oscar Isaac for HBO's 'Scenes From a Marriage' and Himesh Patel for HBO Max's 'Station Eleven'.
Play Quiz: Ranbir Kapoor and Alia Bhatt-starrer Brahmastra
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
